Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v2.4.0.8
CONDENSED BALANCE SHEETS (USD $)
Mar. 31, 2013
Dec. 31, 2012
Current Assets:    
Cash $ 200,146 $ 431
Accounts Receivable 1,478,813  
Total current assets 1,678,959 431
Other Current Assets    
Prepaid Inventory 1,454,716  
Inventory - Raw Oil 850,027  
Total Other Current Assets 2,304,743  
Total Current Assets 3,983,702 431
Property and Equipment, Net 1,288  
Other Assets    
Intangibles, Net 3,973,000  
Goodwill 1,855,512  
Investment in Kannalife 250,000  
Total Other Assets 6,078,512  
TOTAL ASSETS 10,063,502 431
Current Liabilities:    
Accounts payable 280,538  
Amount due to related party 0 500
Other Current Liabilities    
PhytoSphere Agreement 6,927,640 0
Total Current Liabilities 7,208,178 500
Long Term Liabilities    
Line of Credit - Roen Ventures LLC 1,080,500  
Total Long Term Liabilities 1,080,500  
TOTAL LIABILITIES 8,288,678 500
STOCKHOLDERS' EQUITY (DEFICIT)    
Preferred stock, par value $0.0001; 10,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock - par value $0.0001; 190,000,000 shares authorized; 7,900,000 and 7,000,000 shares issued and outstanding as of March 31, 2013 and December 31, 2012 respectively 790 700
Additional paid in capital 1,235,717 143,447
Retained Earnings/Accumulated Deficit 538,317 (144,216)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT) 1,774,824 (69)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $ 10,063,502 $ 431